Washington, D.C., FDA & Life Sciences partner Eva Temkin will speak at the Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries on Dec. 7. Eva will participate in a panel discussion on “The FDCA Impact of Dobbs.”